[
1. Printz C. Spontaneous Regression of Melanoma May Offer Insight Into Cancer Immunology. JNCI J Natl Cancer Inst. 2001;93(14):1047–8.10.1093/jnci/93.14.1047
]Search in Google Scholar
[
2. Shai A, Avinoach I, Sagi A. Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. Case report and review of the literature. J Dermatol Surg Oncol. 1994 May;20(5):342–5.10.1111/j.1524-4725.1994.tb01635.x
]Search in Google Scholar
[
3. Grigore LE, Ungureanu L, Bejinariu N, Seceac C, Vasilovici A, Senila SC, et al. Complete regression of primary melanoma associated with nevi involution under BRAF inhibitors: A case report and review of the literature. Oncol Lett. 2019 May;17(5):4176–82.10.3892/ol.2018.9738
]Search in Google Scholar
[
4. Smith JLJ, Stehlin JSJ. Spontaneous regression of primary malignant melanomas with regional metastases. Cancer. 1965 Nov;18(11):1399–415.10.1002/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R
]Search in Google Scholar
[
5. Avril MF, Charpentier P, Margulis A, Guillaume JC. Regression of primary melanoma with metastases. Cancer. 1992 Mar;69(6):1377–81.10.1002/1097-0142(19920315)69:6<1377::AID-CNCR2820690613>3.0.CO;2-N
]Search in Google Scholar
[
6. Bassi F, Gatti G, Mauri E, Ballardini B, De Pas T, Luini A. Breast metastases from cutaneous malignant melanoma. Breast. 2004 Dec;13(6):533–5.10.1016/j.breast.2004.02.006
]Search in Google Scholar
[
7. Bacchi CE, Wludarski SC, Ambaye AB, Lamovec J, Salviato T, Falconieri G. Metastatic melanoma presenting as an isolated breast tumor: a study of 20 cases with emphasis on several primary mimickers. Arch Pathol & Lab Med [Internet]. 2013 Jan;137(1):41—49.10.5858/arpa.2011-0552-OA
]Search in Google Scholar
[
8. Gewirtzman AJ, Saurat J-H, Braun RP. An evaluation of dermoscopy fluids and application techniques. Br J Dermatol. 2003 Jul;149(1):59–63.10.1046/j.1365-2133.2003.05366.x
]Search in Google Scholar
[
9. Sharma AN, Patel BC. Laser Fitzpatrick Skin Type Recommendations. In Treasure Island (FL); 2022.
]Search in Google Scholar
[
10. Sullivan R. Molecular diagnostics and tumor mutational analysis. In: BRAF Targets in Melanoma-Biological Mechanisms, Resistance and Drug Discovery. New York, NY: Springer; 2015. p. 47–72.10.1007/978-1-4939-2143-0_3
]Search in Google Scholar
[
11. Takada K, Kashiwagi S, Asano Y, Goto W, Morisaki T, Takahashi K, et al. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ. BMC Cancer. 2020 Jun;20(1):513.10.1186/s12885-020-07001-1
]Search in Google Scholar
[
12. Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, et al. Factors predicting microinvasion in Ductal Carcinoma in situ. Asian Pac J Cancer Prev. 2014;15(1):55–60.10.7314/APJCP.2014.15.1.55
]Search in Google Scholar
[
13. Roychowdhury M. Breast Other carcinoma subtypes, WHO classified Mixed NST [Internet]. PathologyOutlines. com. 2022. Available from: https://www.pathologyoutlines.com/topic/breastmixedNST.html
]Search in Google Scholar
[
14. Khan A, Topilow A, Farres O. Stains & CD markers S100. PathologyOutlines.com. 2022.
]Search in Google Scholar
[
15. Matsushima S, Mori M, Adachi Y, Matsukuma A, Sugimachi K. S100 protein positive human breast carcinomas: an immunohistochemical study. J Surg Oncol. 1994 Feb;55(2):108–13.10.1002/jso.2930550210
]Search in Google Scholar
[
16. Cimino-Mathews A. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls. Mod Pathol an Off J United States Can Acad Pathol Inc. 2021 Jan;34(Suppl 1):62–77.10.1038/s41379-020-00697-3
]Search in Google Scholar
[
17. Loffeld A, Marsden JR. Management of melanoma metastasis to the breast: case series and review of the literature. Br J Dermatol. 2005 Jun;152(6):1206–10.10.1111/j.1365-2133.2005.06574.x
]Search in Google Scholar
[
18. Al Samaraee A, Khout H, Barakat T, Fasih T. Breast metastasis from a melanoma. Vol. 12, The Ochsner journal. 2012. p. 149–51.
]Search in Google Scholar
[
19. Vergier B, Trojani M, De Mascarel I, Coindre J-M, Le Treut A. Metastases to the breast: Differential diagnosis from primary breast carcinoma. J Surg Oncol. 1991;48(2):112–6.10.1002/jso.2930480208
]Search in Google Scholar
[
20. Zurac S, Negroiu G, Petrescu S, Andrei R, Tebeica T, Popp C, et al. Spectrum of morphologic alterations of regression in cutaneous melanoma-potential for improving disease prognosis. Rom J Intern Med. 2012;50(2):145–53.
]Search in Google Scholar
[
21. Kim TY, Chae MK, Kim HH, Kim SY, Baek MJ, Lee MS, et al. A Case of Malignant Melanoma Presenting as a Breast Mass. J Korean Breast Cancer Soc [Internet]. 2003 Mar;6(1):35–8. Available from: https://doi.org/10.4048/jkbcs.2003.6.1.35
]Search in Google Scholar
[
22. Verbanck JJ, Rutgeerts LJ, van Aelst FJ, Tyloat JH, Decoster JM, Novez DN, et al. Primary malignant melanoma of the gallbladder, metastatic to the common bile duct. Gastroenterology 1986;91:214-8.10.1016/0016-5085(86)90461-0
]Search in Google Scholar
[
23. Deugnier Y, Turlin B, Lehry D, Pennarun JR, Verger P, Launois B, et al. Malignant melanoma of the hepatic and common bile ducts. Arch Pathol Lab Med 1991;115:915-7.
]Search in Google Scholar
[
24. Bories N, Dalle S, Debarbieux S, Balme B, Ronger-Savlé S, Thomas L. Dermoscopy of fully regressive cutaneous melanoma. Br J Dermatol. 2008 Jun;158(6):1224-9.10.1111/j.1365-2133.2008.08501.x18341656
]Search in Google Scholar
